Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS: ENZN · Delayed Price · USD
0.0750
0.00 (0.00%)
May 3, 2024, 9:30 AM EDT - Market closed
Enzon Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.57M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 26.00K | -675.00K | -96.29% |
Dec 31, 2021 | 701.00K | 649.00K | 1,248.08% |
Dec 31, 2020 | 52.00K | -155.00K | -74.88% |
Dec 31, 2019 | 207.00K | -6.71M | -97.01% |
Dec 31, 2018 | 6.92M | -1.46M | -17.44% |
Dec 31, 2017 | 8.38M | 2.00K | 0.02% |
Dec 31, 2016 | 8.38M | -9.08M | -52.01% |
Dec 31, 2015 | 17.46M | -13.72M | -44.00% |
Dec 31, 2014 | 31.17M | -3.32M | -9.63% |
Dec 31, 2013 | 34.49M | -8.11M | -19.03% |
Dec 31, 2012 | 42.60M | -5.47M | -11.38% |
Dec 31, 2011 | 48.07M | -49.79M | -50.88% |
Dec 31, 2010 | 97.87M | -86.76M | -46.99% |
Dec 31, 2009 | 184.62M | -12.32M | -6.25% |
Dec 31, 2008 | 196.94M | 11.34M | 6.11% |
Dec 31, 2007 | 185.60M | -52.00K | -0.03% |
Dec 31, 2006 | 185.65M | - | - |
Dec 31, 2005 | 0 | - | - |
Jun 30, 2005 | 169.57M | 23.17M | 15.82% |
Jun 30, 2003 | 146.41M | 70.60M | 93.14% |
Jun 30, 2002 | 75.80M | 44.22M | 139.98% |
Jun 30, 2001 | 31.59M | 14.57M | 85.62% |
Jun 30, 2000 | 17.02M | 3.82M | 28.92% |
Jun 30, 1999 | 13.20M | -1.40M | -9.59% |
Jun 30, 1998 | 14.60M | 1.90M | 14.96% |
Jun 30, 1997 | 12.70M | - | - |
Jun 30, 1996 | 12.70M | -3.10M | -19.62% |
Jun 30, 1995 | 15.80M | 1.00M | 6.76% |
Jun 30, 1994 | 14.80M | 6.40M | 76.19% |
Jun 30, 1993 | 8.40M | 2.70M | 47.37% |
Jun 30, 1992 | 5.70M | 3.30M | 137.50% |
Jun 30, 1991 | 2.40M | -100.00K | -4.00% |
Jun 30, 1990 | 2.50M | -200.00K | -7.41% |
Jun 30, 1989 | 2.70M | 2.40M | 800.00% |
Jun 30, 1988 | 300.00K | 200.00K | 200.00% |
Jun 30, 1987 | 100.00K | - | - |
Jun 30, 1986 | 100.00K | - | - |
Jun 30, 1985 | 0 | - | - |
Jun 30, 1984 | 0 | - | - |
Jun 30, 1983 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.33B |
ENZN News
- 3 years ago - Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO - GlobeNewsWire
- 3 years ago - Enzon Pharmaceuticals Announces Results of Rights Offering - GlobeNewsWire
- 3 years ago - Enzon Pharmaceuticals Announces Key Dates for Rights Offering - GlobeNewsWire
- 3 years ago - Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting - GlobeNewsWire
- 4 years ago - Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders - GlobeNewsWire
- 4 years ago - Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value - GlobeNewsWire